tm logo

Monitor this mark

View On USPTO

NXERA
Live/Pending
NON-FINAL ACTION - MAILED

final action

on 02 Dec 2024

Last Applicant/ Owned by

NXERA PHARMA CO., LTD

9-7-2 AKASAKA MINATO-KU

TOKYO

JP

107-0052

Serial Number

98404554 filed on 13th Feb 2024

Registration Number

N/A

Correspondent Address

Eric Lamb

Eric Lamb Frost Brown Todd LLP

Suite 4500

Indianapolis, IN 46204

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

NXERA

Drug and pharmaceutical discovery services; bio-technology, pharmaceutical, chemical and medical testing, research, development, advice, consultancy and information services; research and development services in the pharmaceutical and biopharmaceutical fields, including technologies related to proteins and G-protein-coupled receptors; pharmaceutical research services in chemical and biological dru Read More

Classification Information

Class [044]
Medical, Beauty & Agricultural Services

Pharmaceutical services; pharmaceutical advice and consultancy for medical purposes; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; research, creation, development and provision of chemical and biological drug targets for medical screening purposes; all of the aforesaid relating to drug discovery and use of Gprotein- coupled receptors in the design and development of pharmaceutical products.

First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [042]
Computer & Software Services & Scientific Services

Drug and pharmaceutical discovery services; bio-technology, pharmaceutical, chemical and medical testing, research, development, advice, consultancy and information services; research and development services in the pharmaceutical and biopharmaceutical fields, including technologies related to proteins and G-protein-coupled receptors; pharmaceutical research services in chemical and biological drug discovery and development; research and development services for identifying lead chemical compounds; examination and research services in medicinal and synthetic chemistry; research and development services in the creation of libraries or collections of biologicals, chemicals and compounds; research, creation, development and provision of chemical and biological drug targets for screening purposes; research, analysis and examination for identification of compounds through automated screening processes; research and development services in chemical and biological pharmaceutical development; medical laboratory services; provision of information, advisory services and consultancy relating to the aforesaid services.

First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products

Pharmaceutical preparations; medicines; biological products for medical purposes, namely, G-protein coupled receptors, transmembrane proteins and parts thereof for use in chemical and biological drug discovery, lead identification, diagnostics and therapeutic purposes; biological and chemical products for medical use, namely, proteins, G-protein-coupled receptors, modulators of G-protein coupled receptors, transmembrane proteins, G-proteins, antibodies and peptides and parts thereof, for therapeutic purposes; chemicals, proteins and parts thereof for use in medical diagnostics; biological products for use in chemical and biological drug discovery, lead identification and diagnostics; biological products for therapeutic purposes; biological formulation for developing chemical and biological pharmaceutical products; biological formulation for identifying lead chemical and biological products; biological formulation for diagnostic use; biological formulation for therapeutic use; proteins and G-protein-coupled receptors for drug discovery purposes; biologicals and small chemical entities, including proteins, G-protein-coupled receptors, modulators of G-protein coupled receptors, transmembrane proteins, G-proteins, antibodies and peptides for therapeutic purposes; proteins, Gprotein- coupled receptors, transmembrane proteins, G-proteins, antibodies and peptides for use in medical diagnostics.

First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products

Chemical products and proteins for manufacturing chemical and biological pharmaceutical products; chemical products and proteins for the research of chemical and biological pharmaceutical products; chemical products and proteins for diagnostic use, except medical or veterinary uses; proteins and Gprotein- coupled receptors for manufacturing pharmaceutical products; proteins and G-protein-coupled receptors for the research of pharmaceutical products; chemicals and proteins for chemical and biological drug discovery, lead identification and diagnostics; proteins and G-protein-coupled receptors for drug discovery purposes; chemicals and biologicals, including proteins, transmembrane proteins and G proteins, G-protein-coupled receptors, and fragments thereof being sequences of amino acids, for chemical and biological drug discovery, lead identification and diagnostics; proteins, including transmembrane proteins and G-proteins, G-protein-coupled receptors, and fragments thereof being sequences of amino acids, for use in pharmaceutical research, including, drug discovery purposes.

First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [035]
Advertising, Business & Retail Services

Business management, organisation and administration in the field of chemical products, biological products, pharmaceuticals, design and development of drugs, drug discovery; business management, organisation and administration in the field of research and development services in the pharmaceutical and biopharmaceutical fields, including technologies related to proteins and G-protein-coupled receptors; retail and wholesale services connected with the sale of pharmaceuticals, biological products and chemical and biological preparations.

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 98404554

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

Yes

44D Current

Yes

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

24.09.25 -

Other flags, including bunting and signal flags

26.11.13 -

Two rectangles

26.11.21 -

Rectangles that are completely or partially shaded

26.17.01 -

Straight line(s), band(s) or bar(s)

26.17.05 -

Horizontal line(s), band(s) or bar(s)

Legal History

Show more

Status DateAction Taken
12th Dec 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
12th Dec 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
12th Dec 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02th Dec 2024NON-FINAL ACTION E-MAILED
02th Dec 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
02th Dec 2024NON-FINAL ACTION WRITTEN
16th Jul 2024ASSIGNED TO EXAMINER
04th Jul 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
25th Jun 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25th Jun 2024NOTICE OF DESIGN SEARCH CODE E-MAILED